20147 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals Wall or coating material
Sub-classes:TRANSDERMAL FORMULATION FOR THE TREATMENT OF PAIN AND/OR INFLAMMATION
#2LEVODOPA DOSING REGIMEN
#3Methods and Compositions for Treating Diabetes
#4LEVODOPA DOSING REGIMEN
#5LEVODOPA DOSING REGIMEN
#6Levodopa dosing regimen
#7LEVODOPA DOSING REGIMEN
#8LEVODOPA DOSING REGIMEN
#9Levodopa dosing regimen
#10Levodopa dosing regimen
#11Levodopa dosing regimen
#12Levodopa dosing regimen
#13Levodopa dosing regimen
#14LEVODOPA DOSAGE FORM
#15Methods and Compositions for Treating Diabetes
#16Levodopa dosing regimen
#17HETEROGENEOUS MICROPARTICLES, AND SYSTEMS AND METHODS OF MAKING AND USE THEREOF
#18TRANSDERMAL FORMULATION FOR THE TREATMENT OF PAIN AND/OR INFLAMMATION
#19PREVOTELLA HISTICOLA STRAIN C AS AN ORAL THERAPY FOR INFLAMMATORY DISEASES
#20METHODS AND COMPOSITIONS FOR TREATING DIABETES
#21EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASE
#22Levodopa dosing regimen
#23BIODEGRADABLE MICROCAPSULES
#24Microparticles and nanoparticles having sulfate groups on the surface
#25Transdermal formulation for the treatment of pain and/or inflammation
#26Methods and compositions for treating diabetes
#27Drug delivery systems comprising solid solutions of weakly basic drugs
#28Transdermal formulation for the treatment of pain and/or inflammation
#29PROBIOTIC RECOLONISATION THERAPY
#30Enterically coated cysteamine, cystamine and derivatives thereof
#31ENCAPSULATION OF METAL OXIDE NANOMATERIALS FOR CONTROLLED RELEASE AND TARGETED DELIVERY
#32Methods and Compositions for Treating Diabetes
#33Probiotic recolonisation therapy
#34Reloadable microcapsules
#35Treatment of inflammatory bowel disease
#36Glass Composites for Tissue Augmentation, Biomedical and Cosmetic Applications
#37Enterically coated cysteamine, cystamine and derivatives thereof
#38Probiotic recolonisation therapy
#39Products containing charged polymer complex microcapsules and method of use
#40Microcapsules modified with nanomaterial for controlled release of active agent and process for preparation thereof
#41Delayed release pharmaceutical formulation and methods of making and using same
#42Glass composites for tissue augmentation, biomedical and cosmetic applications
#43Microcellular microstructure and method for manufacturing same
#44Microcapsules comprising a water-immiscible core and a wall comprising the salt of a lewis acid and a lewis base
#45Enterically coated cysteamine, cystamine and derivatives thereof
#46Enterically coated cysteamine, cystamine and derivatives thereof
#47Enterically coated cysteamine, cystamine and derivatives thereof
#48ENCAPSULATION OF ISOQUINOLINE ALKALOIDS
#49Enterically coated cysteamine, cystamine and derivatives thereof
#50Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and T2D
#51Probiotic recolonisation therapy
#52Probiotic recolonisation therapy
#53Probiotic recolonisation therapy
#54Enterically coated cysteamine, cystamine and derivatives thereof
#55Enterically coated cysteamine, cystamine and derivatives thereof
#56Probiotic recolonisation therapy
#57Probiotic recolonisation therapy
#58Delayed release pharmaceutical formulation containing porous carrier particles for colon targeting
#59RODENTICIDE
#60Probiotic recolonisation therapy
#61Probiotic recolonisation therapy
#62Probiotic recolonisation therapy
#63Probiotic recolonisation therapy
#64Enterically coated cysteamine, cystamine and derivatives thereof
#65HMGB1-BINDING BEADS AND USES THEREOF
#66Probiotic recolonisation therapy
#67Probiotic recolonisation therapy
#68IMATINIB SOLID DOSAGE FORMS RECONSTITUTED JUST BEFORE USE
#69Use of Cysteamine and Derivatives Thereof to Treat Mitochondrial Diseases
#70COMPOSITIONS AND METHODS FOR REDUCTION OF MERCURY TOXICITY
#71Methods and compositions for treating diabetes
#72ORGANIC COMPOUNDS
#73Orally disintegrating tablet compositions of lamotrigine
#74Drug delivery systems comprising solid solutions of weakly basic drugs
#75Orally disintegrating tablet compositions of lamotrigine
#76Anti-fouling materials based on poly(β-peptoid)s
#77ORGANIC COMPOUNDS
#78ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
#79Enterically coated cysteamine, cystamine and derivatives thereof
#80Process for production of spherical microparticles comprising tamsulosin hydrochloride
#81Inhibition of the Survival of Oral Cavity Cancer by Cyclohexenone Compounds from Antrodia Camphorata
#82Orally disintegrating tablet compositions of lamotrigine
#83Rodenticide
#84Drug Delivery Catheter using Frangible Microcapsules and Delivery Method
#85ORGANIC COMPOUNDS
#86Orally disintegrating tablet compositions of lamotrigine
#87Enterically coated cystamine, cysteamine and derivatives thereof
#88Microcapsules for removing and absorbing a chemical from a mixture
#89Drug Delivery Systems Comprising Solid Solutions of Weakly Basic Drugs
#90Insulin compensated nutrition
#91Method for treating primary and secondary forms of glaucoma
#92Transdermal formulation for the treatment of pain and/or inflammation
#93Single solid oral dosage forms for treating infection and duodenal ulcer disease